CompletedNCT05903014
N-acetylcysteine with motivational support for nicotine dependence
About this title
Read the official source —Medication studyAges 18–65IndonesiaAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- JakartaSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateStarted: January 1, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 90
- Sponsor
- Universitas Indonesia
- Sponsor type
- Unknown or unclear
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Indonesia
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05903014
- Official title
Show the full official title
Effectiveness of N-Acetylcysteine in Motivational Enhancement Therapy for Nicotine Addiction: Study on the Dopaminergic Pathways, Changes in Functional Connectivity of fMRI Bold, and Changes in Smoking Abstinence
Get this study by email
Recruitment & locations
CompletedJakarta
Questions about this study
Who is behind this study?
The study sponsor is Universitas Indonesia.
Did this study involve medication?
Yes. The study involved medication, including n-acetylcysteine.
Who was this study for?
Listed age limits: 18 years to 65 years.
